You are here
Browse Categories
Offerings On Manhattan Street Capital
Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16th - two days left. Their Oncoprex medicine delivers DNA to lung cancer cells via custom nanoparticles and causes low side effects. The DNA string adjusts cell signaling to trigger cancer cell death. Genprex is raising $6.5 mill at a...
New and Updated Offerings live on Manhattan Street Capital
ERC Homebuilders
Investors in ERC Homebuilders receive an 8% per annum dividend, paid monthly from the date of...
Identify Sensors Biologics
A highly accurate, portable, and reusable COVID self-test for smartphones
Purdue University and IdentifySensors Biologics have partnered to...
Genprex Cancer IPO launch, Muscle Maker Grill Reg A+ IPO, InsituBiologics RegD Biotech near its goal
Genprex is raising capital through their IPO to progress Clinical trials for their Gene Therapy lung cancer treatment.
Genprex has developed Oncoprex, a unique medicine...
ERC Homebuilders Inc. - Max raise $50mill. Anyone can invest
ERC develops "build-to-rent" homes to capitalize on market demand driven by the cultural wave of millennials...
I am pleased to announce two new offerings on Manhattan Street Capital, TransCode Therapeutics and GolfSuites 1, and update you on our platform's ongoing offerings....
Reg A+ offerings - Anyone can invest
GolfSuites 1 - Anyone can invest
"GolfSuites is a new investment opportunity focused on bringing hybrid-golf...
Most active Reg A+ offerings on Manhattan Street Capital
GolfSuites 1
Investors in GolfSuites 1 receive an 8% per annum dividend (see the Offering Circular for the...
Reg A+ IPO begins for Muscle Maker Grill, AnestaGel 34% funded, SkyDrop and Radiant in RegA+Audition
Muscle Maker, Inc. Reg A+ IPO Raising $20 mill at $51 mill pre-money valuation, plans to List on the NYSE in January. Underwritten by Tripoint.
Muscle Maker Grill is a...